These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12106979)

  • 1. Characterization of crosslinked high amylose starch matrix implants. 1. In vitro release of ciprofloxacin.
    Désévaux C; Dubreuil P; Lenaerts V
    J Control Release; 2002 Jul; 82(1):83-93. PubMed ID: 12106979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of crosslinked high amylose starch matrix implants. 2. In vivo release of ciprofloxacin.
    Désévaux C; Lenaerts V; Girard C; Dubreuil P
    J Control Release; 2002 Jul; 82(1):95-103. PubMed ID: 12106980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-properties relationship in cross-linked high-amylose starch for use in controlled drug release.
    Ispas-Szabo P; Ravenelle F; Hassan I; Preda M; Mateescu MA
    Carbohydr Res; 2000 Jan; 323(1-4):163-75. PubMed ID: 10782298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of binary mixtures consisting of cross-linked high amylose starch and hydroxypropylmethylcellulose used in the preparation of controlled release tablets.
    Rahmouni M; Lenaerts V; Massuelle D; Doelker E; Johnson M; Leroux JC
    Pharm Dev Technol; 2003; 8(4):335-48. PubMed ID: 14601958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin-loaded crosslinked high amylose starch implants.
    Huneault LM; Lussier B; Dubreuil P; Chouinard L; Désévaux C
    J Orthop Res; 2004 Nov; 22(6):1351-7. PubMed ID: 15475220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-unit floating alginate system: effect of additives on ciprofloxacin release.
    Srinatha A; Pandit JK
    Drug Deliv; 2008 Sep; 15(7):471-6. PubMed ID: 18712625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix polymeric excipients: comparing a novel interpolyelectrolyte complex with hydroxypropylmethylcellulose.
    Lu Z; Chen W; Olivier E; Hamman JH
    Drug Deliv; 2008 Feb; 15(2):87-96. PubMed ID: 18293194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of excipient and processing on solid phase transformation and dissolution of ciprofloxacin.
    Li X; Zhi F; Hu Y
    Int J Pharm; 2007 Jan; 328(2):177-82. PubMed ID: 16978809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linked high amylose starch for controlled release of drugs: recent advances.
    Lenaerts V; Moussa I; Dumoulin Y; Mebsout F; Chouinard F; Szabo P; Mateescu MA; Cartilier L; Marchessault R
    J Control Release; 1998 Apr; 53(1-3):225-34. PubMed ID: 9741930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane formation and drug loading effects in high amylose starch tablets studied by NMR imaging.
    Thérien-Aubin H; Zhu XX; Ravenelle F; Marchessault RH
    Biomacromolecules; 2008 Apr; 9(4):1248-54. PubMed ID: 18357992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of excipients on drug release from hydroxypropyl methylcellulose matrices.
    Levina M; Rajabi-Siahboomi AR
    J Pharm Sci; 2004 Nov; 93(11):2746-54. PubMed ID: 15389670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-linked high amylose starch derivatives for drug release III. Diffusion properties.
    Mulhbacher J; Mateescu MA
    Int J Pharm; 2005 Jun; 297(1-2):22-9. PubMed ID: 15878244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin implants for bone infection. In vitro-in vivo characterization.
    Castro C; Sánchez E; Delgado A; Soriano I; Núñez P; Baro M; Perera A; Evora C
    J Control Release; 2003 Dec; 93(3):341-54. PubMed ID: 14644584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of formulation change on drug release kinetics from hydroxypropylmethylcellulose matrix tablets.
    Xu G; Sunada H
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):483-7. PubMed ID: 7774032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a crosslinked high amylose starch excipient.
    Le Bail P; Morin FG; Marchessault RH
    Int J Biol Macromol; 1999 Nov; 26(2-3):193-200. PubMed ID: 10517529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of casein on diclofenac release from hydroxypropylmethylcellulose (HPMC) compacts.
    Gubbins RH; O'Driscoll CM; Corrigan OI
    Int J Pharm; 2003 Jul; 260(1):69-76. PubMed ID: 12818811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the amylose-amylopectin ratio on starch-hydrocolloid interactions.
    Kim HS; Patel B; BeMiller JN
    Carbohydr Polym; 2013 Nov; 98(2):1438-48. PubMed ID: 24053825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug release: development of a spray-drying manufacturing process.
    Brouillet F; Baylac G; Cartilier L; Bataille B
    Drug Dev Ind Pharm; 2010 Jul; 36(7):795-805. PubMed ID: 20136492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.